Broncho-Vaxom Adults/Children capsules

Broncho-Vaxom Children

3.5mg of a lyophilized bacterial lysate of Haemophilus influenzae. Diplococcus pneumoniae, klebsiella pneumoniae, ozaenae, Staphylococcus aureus, Streptococcus pyogenes and viridans Neisseria catarrhatis.

Broncho-Vaxom Adults

7mg of a lyophilized bacterial lysate of Haemophilus influenzae. Diplococcus pneumoniae, klebsiella pneumoniae, ozaenae, Staphylococcus aureus, Streptococcus pyogenes and viridans Neisseria catarrhatis.








Company Name
Memphis/OM

Broncho-Vaxom Therapeutic Group
VACCINES

Pharmaceutical form
Capsule

Broncho-Vaxom Package

Broncho-vaxom Adults: 10 capsules.

Broncho-Vaxom Indications

Adjuvant therapy in all infections of the respiratory system and of the ears, nose or throat. Prevention of recurrences and of transition of the chronic state.
Broncho-vaxom is especially recommended as adjuvant therapy in:
-Acute and chronic bronchitis.
- Sore throat, tonsillitis, pharyngitis, and laryngitis.
- Rhinitis sinusitis and otitis.
- infections resistant to conventional antibiotics.
- Bacterial complications of viral infections of the respiratory system especially in children and the elderly.


Warning and Precautions
NA


Product Type
Human

Broncho-Vaxom Dosage

-Treatment of acute episode; one capsule daily on an empty stomach until the symptoms disappear but for not, less than 10 days. -In cases in which antibiotics are needed, Broncho-vaxom should be given in addition to the antibiotics right from the start of therapy. -Consolidation therapy one capsule daily on 10 consecutive days per month for three months.

Broncho-Vaxom Adverse Reactions

There are no allergic reactions have been reported.

Broncho-Vaxom Contra Indications

There are no contraindications have been reported.

Drug Interactions
NA

Search Post

Label :